American Heart Journal
Volume 147, Issue 2 , Pages 210-217 , February 2004

Long-term care of the patient with the atrial defibrillator

  • Andrew Robert John Mitchell, BM, MRCP

      Affiliations

    • Department of Cardiology, Eastbourne General Hospital, Eastbourne, United Kingdom
    • Corresponding Author InformationReprint requests: Andrew RJ Mitchell, BM, MRCP, Department of Cardiac Rhythm Management, Level 2, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
    • ,
  • Philip Anthony Roworth Spurrell, MBBS, MRCP

      Affiliations

    • Department of Cardiology, Eastbourne General Hospital, Eastbourne, United Kingdom
    • ,
  • Lana Elizabeth Boodhoo, MBBS, MRCP

      Affiliations

    • Department of Cardiology, Eastbourne General Hospital, Eastbourne, United Kingdom
    • ,
  • Neil Sulke, BM, DM, FRCP, FACC

      Affiliations

    • Department of Cardiology, Eastbourne General Hospital, Eastbourne, United Kingdom

Received 4 March 2003 ,Accepted 3 July 2003.

References 

  1. Stewart S, Hart CL, Hole DJ, et al.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86:516–521
  2. Go AS, Hylek EM, Phillips KA, et al.  Prevalence of diagnosed atrial fibrillation in adults (national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study). JAMA. 2001;285:2370–2375
  3. The AFFIRM investigators . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  4. Mitchell AR. Atrial fibrillation in the new millennium—the role of pacemaker and defibrillator therapy. Med Sci Monitor. 2002;8:RA233–239
  5. Hindricks G, Kottkamp H. Potential benefits, risks, and complications of catheter ablation of atrial fibrillation (more questions than answers). J Cardiovasc Electrophysiol. 2002;13:768–769
  6. Camm AJ. The atrial fibrillation therapy study. Pacing Clin Electrophysiol. 2002;24:554
  7. Daoud EG, Timmermans C, Fellows C, et al.  Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators. Circulation. 2000;102:1407–1413
  8. Gold MR, Sulke N, Schwartzman D, et al.  Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 2001;12:1247–1253
  9. Gillis AM, Unterberg-Buchwald C, Schmidinger H, et al.  Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol. 2002;40:1653–1659
  10. Boriani G, Wollmann C, Biffi M, et al.  Evaluation of a dual chamber ICD for the treatment of atrial and ventricular arrhythmias. Europace. 2002;3:A41
  11. Seidl K, Hauer B, Kirca M, et al.  Importance of preimplantation procedures in candidates for an implantable atrial defibrillator. J Cardiovasc Electrophysiol. 1998;9:S127–131
  12. Steinhaus DM, Cardinal DS, Mongeon L, et al.  Internal defibrillation (pain perception of low energy shocks). Pacing Clin Electrophysiol. 2002;25:1090–1093
  13. Mitchell AR, Spurrell PA, Boodhoo L, et al.  Psychosocial aspects of patient-activated atrial defibrillation. J Cardiovasc Electrophysiol. 2003;14:1–5
  14. Mitchell AR, Spurrell PA, Kamalvand K, et al.  What is the optimal electrode configuration for atrial defibrillators in man?. Europace. 2002;4:41–44
  15. Mitchell AR, Spurrell PA, Ahmet H, et al.  Echocardiographic changes and predictors of arrhythmia recurrence after long-term use of the atrial defibrillator. Int J Cardiol. 2003;89:25–31
  16. Spurrell PA, Mitchell AR, Kamalvand K, et al.  The impact of atrial defibrillators on the natural history of persistent atrial fibrillation (does sinus rhythm beget more sinus rhythm?). J Am Coll Cardiol. 2001;37:95A
  17. Schwartzman D, Hoyt RH, Sulke N, et al.  Patterns of coumadin use and cerebrovascular accident in patients implanted with the Jewel AF device. Pacing Clin Electrophysiol. 2001;24:639
  18. Lok NS, Lau CP, Tse HF, et al.  Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol. 1997;30:1324–1330
  19. Murgatroyd FD, Slade AK, Sopher SM, et al.  Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 1995;25:1347–1353
  20. Kidwai BJ, Allen JD, Harbinson MT, et al.  Waveform optimization for internal atrial defibrillation (effects of waveform rounding, phase duration, and voltage swing). Pacing Clin Electrophysiol. 2001;24:1198–1207
  21. Boriani G, Biffi M, Bronzetti G, et al.  Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol. 1998;81:241–244
  22. Timmermans C, Nabar A, Rodriguez LM, et al.  Use of sedation during cardioversion with the implantable atrial defibrillator. Circulation. 1999;100:1499–1501
  23. Haffajee CI, Chaudhry GM, Casavant D, et al.  Efficacy and tolerability of automatic nighttime atrial fibrillation shocks in patients with permanent internal atrial defibrillators. Am J Cardiol. 2002;89:875–878
  24. Ujhelyi MR, Sears SF, Burns JL, et al.  Characterization of atrial shock pain from implantable atrial defibrillator (patient activated vs. automatic nighttime atrial shocks). Pacing Clin Electrophysiol. 2002;24:712
  25. Timmermans C, Rodriguez LM, Ayers GM, et al.  Effect of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation. 1999;99:1837–1842
  26. Mitchell AR, Spurrell PA, Sulke N. The atrial defibrillator sedation assessment study (ADSAS). Int J Cardiol 2004 (in press)
  27. Swerdlow CD, Schsls W, Dijkman B, et al.  Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. Circulation. 2000;101:878–885
  28. Mitchell AR, Spurrell PA, Cheatle L, et al.  Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator (randomised study comparing subthreshold and nominal pacing outputs). Heart. 2002;87:433–437
  29. Lau CP, Tse HF. Early reinitiation of atrial fibrillation after electrical defibrillation (a new electrophysiological phenomenon). Pacing Clin Electrophysiol. 2001;24:1581–1584
  30. Swerdlow CD, Schwartzman D, Hoyt R, et al.  Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2002;13:347–354
  31. Schwartzman D, Musley SK, Swerdlow C, et al.  Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol. 2002;40:93–99
  32. Dijkman B, Wellens HJ. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator. J Interv Card Electrophysiol. 2001;5:309–318
  33. Mitchell AR, Spurrell PA, Sulke N. Atrial fibrillation storms. Int J Clin Pract. 2003;57:349–350
  34. Shehadeh LA, Liebovitch LS, Wood MA. Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators (implications for assessing antiarrhythmic therapies). J Cardiovasc Electrophysiol. 2002;13:303–309
  35. Mitchell AR, Spurrell PA, Kamalvand K, et al. The circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. Am Heart J 2003;146:902–7
  36. Behrens S, Ehlers C, Bruggemann T, et al.  Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy. Clin Cardiol. 1997;20:253–257
  37. Page RL, Wilkinson WE, Clair WK, et al.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994;89:224–227
  38. Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;87:488–493
  39. Weretka S, Becker R, Hilbel T, et al.  Far-field R wave oversensing in a dual chamber arrhythmia management device (predisposing factors and practical implications). Pacing Clin Electrophysiol. 2001;24:1240–1246
  40. Moss AJ, Zareba W, Hall WJ, et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  41. Sears SF, Todaro JF, Urizar G, et al.  Assessing the psychosocial impact of the ICD (a national survey of implantable cardioverter defibrillator health care providers). Pacing Clin Electrophysiol. 2000;23:939–945
  42. Davis LL, Vitale KA, Irmiere CA, et al.  Psychosocial adaptation of patients in a long-term pacemaker trial. Pacing Clin Electrophysiol. 2002;24:551
  43. Sears SF, Burns JL, Schwartzman D, et al.  Do patients accept implantable atrial device therapy?. Pacing Clin Electrophysiol. 2002;25:596

PII: S0002-8703(03)00578-7

doi: 10.1016/j.ahj.2003.07.017

American Heart Journal
Volume 147, Issue 2 , Pages 210-217 , February 2004

Article Tools

* Image Usage & Resolution